• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

世界卫生组织胰腺神经内分泌肿瘤新分类。

The New World Health Organization Classification for Pancreatic Neuroendocrine Neoplasia.

机构信息

Department of Anatomic Pathology, IRCCS Fondazione Policlinico Universitario A. Gemelli, Largo A. Gemelli, 8, Roma I-00168, Italy; Roma ENETS Center of Excellence, IRCCS Fondazione Policlinico Universitario A. Gemelli, Largo A. Gemelli, 8, Roma I-00168, Italy; Gynecological and Breast Pathology Unit, IRCCS Fondazione Policlinico Universitario A. Gemelli, Largo A. Gemelli, 8, Roma I-00168, Italy.

Department of Anatomic Pathology, IRCCS Fondazione Policlinico Universitario A. Gemelli, Largo A. Gemelli, 8, Roma I-00168, Italy; Roma ENETS Center of Excellence, IRCCS Fondazione Policlinico Universitario A. Gemelli, Largo A. Gemelli, 8, Roma I-00168, Italy; Anatomic Pathology Unit, IRCCS Fondazione Policlinico Universitario A. Gemelli, Largo A. Gemelli, 8, Roma I-00168, Italy.

出版信息

Endocrinol Metab Clin North Am. 2018 Sep;47(3):463-470. doi: 10.1016/j.ecl.2018.04.008. Epub 2018 Jul 11.

DOI:10.1016/j.ecl.2018.04.008
PMID:30098710
Abstract

Based on the 2010 version, the 2017 World Health Organization (WHO 2017) classification is for pancreatic neuroendocrine neoplasms (PanNEN). The WHO 2017 classification introduces the novel well-differentiated neuroendocrine tumor of high grade (NET G3). A sharp distinction between NET and poorly differentiated neuroendocrine carcinoma (NEC) is emphasized to highlight substantial biological differences. Further changes comprise the definition of mixed neuroendocrine non-neuroendocrine neoplasm (MiNEN), to accommodate all grades of both neoplasm components, and the abolition of preneoplastic lesions given their rarity in the pancreas. The 2017 American Joint Cancer Committee classification (AJCC 2017) adopts such a classification for all digestive sites.

摘要

基于 2010 年版,2017 年世界卫生组织(WHO 2017)分类是用于胰腺神经内分泌肿瘤(PanNEN)的。WHO 2017 分类引入了新型高级别分化良好的神经内分泌肿瘤(NET G3)。强调了 NET 与低分化神经内分泌癌(NEC)的明显区别,以突出其生物学上的显著差异。进一步的变化包括混合性神经内分泌-非神经内分泌肿瘤(MiNEN)的定义,以适应两种肿瘤成分的所有级别,并取消了因在胰腺中罕见而被认为是癌前病变的病变。2017 年美国癌症联合委员会分类(AJCC 2017)采用了这种分类方法,适用于所有消化道部位。

相似文献

1
The New World Health Organization Classification for Pancreatic Neuroendocrine Neoplasia.世界卫生组织胰腺神经内分泌肿瘤新分类。
Endocrinol Metab Clin North Am. 2018 Sep;47(3):463-470. doi: 10.1016/j.ecl.2018.04.008. Epub 2018 Jul 11.
2
A Practical Approach to the Classification of WHO Grade 3 (G3) Well-differentiated Neuroendocrine Tumor (WD-NET) and Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) of the Pancreas.胰腺WHO 3级(G3)高分化神经内分泌肿瘤(WD-NET)和低分化神经内分泌癌(PD-NEC)分类的实用方法
Am J Surg Pathol. 2016 Sep;40(9):1192-202. doi: 10.1097/PAS.0000000000000662.
3
Comparison of World Health Organization 2000/2004 and World Health Organization 2010 classifications for gastrointestinal and pancreatic neuroendocrine tumors.世界卫生组织2000/2004年与世界卫生组织2010年胃肠道和胰腺神经内分泌肿瘤分类的比较。
Ann Diagn Pathol. 2015 Apr;19(2):81-7. doi: 10.1016/j.anndiagpath.2015.01.001. Epub 2015 Jan 9.
4
Classification and pathology of gastroenteropancreatic neuroendocrine neoplasms.胃肠胰神经内分泌肿瘤的分类和病理学。
Endocr Relat Cancer. 2011 Oct 17;18 Suppl 1:S1-16. doi: 10.1530/ERC-11-0013. Print 2011 Oct.
5
[Classification of pancreatic neuroendocrine tumours: Changes made in the 2017 WHO classification of tumours of endocrine organs and perspectives for the future].[胰腺神经内分泌肿瘤的分类:2017年世界卫生组织内分泌器官肿瘤分类的变化及未来展望]
Ann Pathol. 2017 Dec;37(6):444-456. doi: 10.1016/j.annpat.2017.10.003. Epub 2017 Nov 21.
6
The high-grade (WHO G3) pancreatic neuroendocrine tumor category is morphologically and biologically heterogenous and includes both well differentiated and poorly differentiated neoplasms.高级别(世界卫生组织G3级)胰腺神经内分泌肿瘤类别在形态学和生物学上具有异质性,包括高分化和低分化肿瘤。
Am J Surg Pathol. 2015 May;39(5):683-90. doi: 10.1097/PAS.0000000000000408.
7
Comparison of WHO 2000 and WHO 2010 classifications of gastroenteropancreatic neuroendocrine tumors.世界卫生组织2000年与2010年胃肠胰神经内分泌肿瘤分类的比较。
Turk J Gastroenterol. 2014 Feb;25(1):81-7. doi: 10.5152/tjg.2014.6579.
8
Clinical outcome and long-term survival of 150 consecutive patients with pancreatic neuroendocrine tumors: A comprehensive analysis by the World Health Organization 2010 grading classification.150例连续性胰腺神经内分泌肿瘤患者的临床结局及长期生存情况:基于世界卫生组织2010年分级分类的综合分析
Clin Res Hepatol Gastroenterol. 2018 Jun;42(3):261-268. doi: 10.1016/j.clinre.2017.09.004. Epub 2018 Jan 5.
9
The Eighth Edition of the American Joint Committee on Cancer Distant Metastases Stage Classification for Metastatic Pancreatic Neuroendocrine Tumors Might Be Feasible for Metastatic Pancreatic Ductal Adenocarcinomas.美国癌症联合委员会第八版转移性胰腺神经内分泌肿瘤远处转移分期分类可能适用于转移性胰腺导管腺癌。
Neuroendocrinology. 2020;110(5):364-376. doi: 10.1159/000502382. Epub 2019 Jul 30.
10
Prognostic Validity of the American Joint Committee on Cancer and the European Neuroendocrine Tumors Staging Classifications for Pancreatic Neuroendocrine Tumors: A Retrospective Nationwide Multicenter Study in South Korea.美国癌症联合委员会和欧洲神经内分泌肿瘤分期分类对胰腺神经内分泌肿瘤的预后有效性:韩国一项全国性多中心回顾性研究
Pancreas. 2016 Aug;45(7):941-6. doi: 10.1097/MPA.0000000000000586.

引用本文的文献

1
The PANEN nomogram: clinical decision support for patients with metastatic pancreatic neuroendocrine neoplasm referred for peptide receptor radionuclide therapy.PANEN列线图:为接受肽受体放射性核素治疗的转移性胰腺神经内分泌肿瘤患者提供临床决策支持。
Front Endocrinol (Lausanne). 2025 Jun 24;16:1514792. doi: 10.3389/fendo.2025.1514792. eCollection 2025.
2
Recent research advances in interleukin, microRNA and neuroendocrine tumor biomarkers (Review).白细胞介素、微小RNA与神经内分泌肿瘤生物标志物的最新研究进展(综述)
Mol Clin Oncol. 2025 Jun 17;23(2):71. doi: 10.3892/mco.2025.2866. eCollection 2025 Aug.
3
The role of artificial intelligence and deep learning in determining the histopathological grade of pancreatic neuroendocrine tumors by using EUS images.
人工智能和深度学习在利用超声内镜(EUS)图像确定胰腺神经内分泌肿瘤组织病理学分级中的作用。
Endosc Ultrasound. 2025 Mar-Apr;14(2):48-56. doi: 10.1097/eus.0000000000000113. Epub 2025 May 2.
4
Radiological Variability in Pancreatic Neuroendocrine Neoplasms: A 10-Year Single-Center Study on Atypical Presentations and Diagnostic Challenges.胰腺神经内分泌肿瘤的放射学变异性:一项关于非典型表现和诊断挑战的10年单中心研究
Biomedicines. 2025 Feb 17;13(2):496. doi: 10.3390/biomedicines13020496.
5
Potential neuroendocrine differentiation in poorly differentiated colorectal adenocarcinoma: A hidden trait?低分化结直肠癌中潜在的神经内分泌分化:一种隐匿特征?
Mol Clin Oncol. 2024 Oct 3;21(6):91. doi: 10.3892/mco.2024.2789. eCollection 2024 Dec.
6
Recurrence and treatment trends of pancreatic neuroendocrine tumors.胰腺神经内分泌肿瘤的复发及治疗趋势
Surgery. 2025 Jan;177:108835. doi: 10.1016/j.surg.2024.05.051. Epub 2024 Oct 4.
7
Peptide Receptor Radionuclide Therapy versus Capecitabine/Temozolomide for the Treatment of Metastatic Pancreatic Neuroendocrine Tumors.肽受体放射性核素治疗与卡培他滨/替莫唑胺治疗转移性胰腺神经内分泌肿瘤的对比研究
Cancers (Basel). 2024 Aug 28;16(17):2993. doi: 10.3390/cancers16172993.
8
Well-differentiated G1 and G2 pancreatic neuroendocrine tumors: a meta-analysis of published expanded DNA sequencing data.高分化G1和G2胰腺神经内分泌肿瘤:已发表的扩展DNA测序数据的荟萃分析
Front Endocrinol (Lausanne). 2024 May 29;15:1351624. doi: 10.3389/fendo.2024.1351624. eCollection 2024.
9
Multicenter validation study of a treatment selection MAP for pancreatic neuroendocrine tumors.多中心验证研究一种用于胰腺神经内分泌肿瘤的治疗选择 MAP。
Jpn J Clin Oncol. 2024 Aug 14;54(8):880-886. doi: 10.1093/jjco/hyae052.
10
Combined deletion of MEN1, ATRX and PTEN triggers development of high-grade pancreatic neuroendocrine tumors in mice.联合缺失 MEN1、ATRX 和 PTEN 可导致小鼠发生高级别胰腺神经内分泌肿瘤。
Sci Rep. 2024 Apr 12;14(1):8510. doi: 10.1038/s41598-024-58874-2.